Results 221 to 230 of about 78,942 (265)

Reasons for Healthcare Use Before Onset of Multiple Sclerosis: A Nationwide Matched Cohort Study in Sweden

European Journal of Neurology, Volume 32, Issue 12, December 2025.
Healthcare and medication use related to multiple body systems elevated up to 6–9 years before multiple sclerosis (MS) symptom onset, and even earlier before the first demyelinating event. The timing and magnitude varied by sex and age. ABSTRACT Background Evidence suggests signs and symptoms may emerge years before the clinical onset of multiple ...
Ali Manouchehrinia, Yinshan Zhao, Feng Zhu, Kyla McKay, Colleen Maxwell, Ruth Ann Marrie, Helen Tremlett   +6 more
wiley   +1 more source

Gout flares following acute stroke: a single-center cohort and a systematic review/meta-analysis. [PDF]

Neurol Res Pract
Panagiotopoulos E, Kotsali-Peteinelli V, Papagiannopoulou G, Theodorou A, Chondrogianni M, Bakola E, Palaiodimou L, Psychogios K, Kargiotis O, Safouris A, Tsalouchidou PE, Mengel A, Ziemann U, Krogias C, Tsivgoulis G, Stefanou MI.   +15 more
europepmc   +1 more source

Low Alanine Aminotransferase Levels in Alcohol Consuming Male Subjects, Carriers of the Common ALDH2 Deficient Variant, ALDH2*2

Hepatology Research, Volume 55, Issue 12, Page 1576-1588, December 2025.
ABSTRACT Alanine aminotransferase (ALT) is a commonly used indicator of hepatocellular injury in clinical liver disease practice. While a variety of factors influence serum ALT levels, we focus here on the effect of alcohol consumption on ALT levels in the context of the common East Asian aldehyde dehydrogenase 2 (ALDH2) dysfunctional polymorphism ...
Takuya Seike, Che‐Hong Chen, Eishiro Mizukoshi, Daria Mochly‐Rosen   +3 more
wiley   +1 more source

Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study. [PDF]

Front Pharmacol
Wang W, Wang SI, Cheng Y, Wang X, Fan Y, Wei JC.   +5 more
europepmc   +1 more source

Gout in the "Anonymus Parisinus". [PDF]

J Nephrol
De Santo NG, De Santo LS, Bisaccia C.
europepmc   +1 more source

Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials

Journal of Internal Medicine, Volume 298, Issue 6, Page 711-717, December 2025.
Abstract Background Colchicine shows promise in reducing cardiovascular risk, but a recent study raised the question whether this is really the case. We conducted a meta‐analysis of randomized controlled trials (RCTs) to assess its impact on cardiovascular outcomes in secondary prevention.
Sining Xie, Federica Galimberti, Elena Olmastroni, Alberico L. Catapano, Manuela Casula   +4 more
wiley   +1 more source

Exploring Immunological Determinants and Constructing a Predictive Model for for Diagnosis of Gout: Insights Into Immune Biomarkers. [PDF]

J Inflamm Res
Zeng H, Zheng L, Wu D, Yu X, Zhang G, Du J.   +5 more
europepmc   +1 more source

Development and validation of a multidimensional and interpretable artificial intelligence model to predict gout recurrence in hospitalised patients: a real-world, ambispective multicentre cohort study in China. [PDF]

BMC Med
Li M, Zhang H, Chen S, Zhong F, Liu J, Wu J, Lin R, Li R, Wu Y, Xie D, Zhang K, Zheng B, Chen X, Cheng Z, Jiang Y, Ye H, Cai L, Xie R, Li D, Zhu J, Li J.   +20 more
europepmc   +1 more source

Sugar-sweetened beverages and the risk of hyperuricemia and gout: a meta-analysis. [PDF]

Front Nutr
Lu Y, Wang Y, Huang R, Pan H, Xie Z, Wen C, Huang L, Li X.   +7 more
europepmc   +1 more source

Chinese medical students' perceptions of gout: a pilot study. [PDF]

BMC Med Educ
Wang Y, Wang Y, Yin Y, Han X, Xu N, Zhang Y, Zeng X.   +6 more
europepmc   +1 more source